• user warning: Table './fnndrupaldev/term_node' is marked as crashed and last (automatic?) repair failed query: SELECT t.* FROM term_node r INNER JOIN term_data t ON r.tid = t.tid INNER JOIN vocabulary v ON t.vid = v.vid WHERE r.vid = 521245 ORDER BY v.weight, t.weight, t.name in /var/www/www.fnno.com/htdocs/modules/taxonomy/taxonomy.module on line 617.
  • user warning: Table './fnndrupaldev/sessions' is marked as crashed and last (automatic?) repair failed query: SELECT COUNT(sid) AS count FROM sessions WHERE timestamp >= 1414057874 AND uid = 0 in /var/www/www.fnno.com/htdocs/includes/session.inc on line 111.
  • user warning: Table './fnndrupaldev/sessions' is marked as crashed and last (automatic?) repair failed query: SELECT DISTINCT u.uid, u.name, s.timestamp FROM users u INNER JOIN sessions s ON u.uid = s.uid WHERE s.timestamp >= 1414057874 AND s.uid > 0 ORDER BY s.timestamp DESC in /var/www/www.fnno.com/htdocs/modules/user/user.module on line 765.

Investors look to Lighten Up on Shares of Pacific Biosciences of California , Shares Down 6.8% (PACB)

Published on Fri, 06/21/2013 - 12:28
By Adrienne Chilton

Pacific Biosciences of California (NASDAQ:PACB) is one of today's worst performing low-priced stocks, down 6.8% to $2.47 on 1.1x average daily volume. Thus far today, Pacific Biosciences of California has traded 477,000 shares, vs. average volume of 453,000 shares per day. The stock has underperformed the Dow (-6.8% to the Dow's 0.3%) and underperformed the S&P 500 (-6.8% to the S&P's 0.2%) during today's trading.

Pacific Biosciences of California Inc. has developed a novel approach to studying the synthesis and regulation of DNA, RNA and protein. The Company's system enables real-time analysis of biomolecules with single molecule resolution.

In the past 52 weeks, Pacific Biosciences of California share prices have been bracketed by a low of $1.06 and a high of $3.25 and are now at $2.47, 133% above that low price. The 200-day and 50-day moving averages have moved 0.87% higher and 1.56% higher over the past week, respectively.

Potential upside of 6.6% exists for Pacific Biosciences of California , based on a current level of $2.47 and analysts' average consensus price target of $2.63. The stock should hit resistance at its 50-day moving average (MA) of $2.52, as well as support at its 200-day MA of $2.09.

By Adrienne Chilton
achilton@fnno.com

Latest News from FNNO

Tesoro: 52-Week High Recently Eclipsed (...

Tesoro (NYSE:TSO) traded at a new 52-week high today of $68.26. This new high was reac ...

Travelers Looks to Continue to Trade Abo...

Shares of Travelers (NYSE:TRV) traded at a new 52-week high today of $96.29. This new ...

Shares of TECO Energy Rise Above Previou...

TECO Energy (NYSE:TE) traded at a new 52-week high today of $19.25. Approximately 2.3 ...

Recent 52-Week High Exceeded in Shares o...

STERIS (NYSE:STE) traded at a new 52-week high today of $58.58. So far today approxima ...

Sovran Self Storage: The Winning Streak ...

Sovran Self Storage (NYSE:SSS) traded at a new 52-week high today of $82.00. So far to ...

Sonic: 52-Week High Recently Eclipsed (S...

Sonic (NASDAQ:SONC) traded at a new 52-week high today of $24.89. Approximately 1.2 mi ...

Snap-On Looks to Continue to Trade Above...

Snap-On (NYSE:SNA) traded at a new 52-week high today of $128.65. Approximately 354,00 ...

Super Micro Computer: The Winning Streak...

Shares of Super Micro Computer (NASDAQ:SMCI) traded at a new 52-week high today of $30. ...